Fermentation Defoamer 510 is a non-silicone polyether antifoam used in submerged fermentation where foam is stabilised by extracellular proteins, polysaccharides, cell debris, and sparged gas. Performance depends on cloud point-dependent spreading, lamella drainage, and compatibility with downstream separations. Industrial dosing ranges are process-specific and are constrained by oxygen transfer efficiency, broth viscosity, and final product purity requirements.

In Bacillus subtilis protease and amylase production conducted in stirred-tank vessels of 150 m³ to 200 m³, foam collapse becomes critical during late exponential phase when cell lysis releases surface-active lipopeptides and hydrolysed medium proteins. Typical aeration is 0.5–1.5 vvm, agitator tip speed is 3–5 m/s, and backpressure is held at 0.3–0.5 bar g to maintain dissolved oxygen above 20% saturation. Defoamer 510 is introduced as a sterile-filtered solution through a peristaltic pump at an initial charge of 0.1–0.3 g/L; continuous feed of 0.02–0.08 g/L/h is then adjusted by a foam probe mounted in the headspace. Bolus additions above 0.5 g/L are avoided because polyether films accumulate at the gas–liquid interface and reduce the volumetric oxygen transfer coefficient by 20–40% within 15–30 min, forcing agitation upshift and increasing shear damage to bacilli. The downstream enzyme broth is clarified by disc-stack centrifugation and polished with ion-exchange chromatography; residual antifoam is removed with the spent biomass and spent resin such that final food-grade protease complies with the purity criteria referenced in FAO/WHO JECFA monographs and FDA 21 CFR 173.340. Terminal products include alkaline serine protease and thermostable α-amylase for bakery, detergent, and animal nutrition applications.

What foam destabilisation thresholds control high-gravity Saccharomyces cerevisiae ethanol fermentation?

Whole corn mash is liquefied at 85–90 °C and pH 5.8–6.2 with thermostable α-amylase, then cooled to 32–34 °C for simultaneous saccharification and fermentation. Dry solids loading of 30–34 wt% creates a non-Newtonian slurry with apparent viscosity sometimes exceeding 1,500 mPa·s at shear rates below 10 s⁻¹ as determined by ISO 3219-type rotational viscometry. Foam in the fermenter is not a single-phase collapse problem; it arises from CO₂ nucleation in a high-protein, high-lipid, glucan-containing matrix where yeast extracellular mannoproteins and lipid degradation products form elastic lamellae. Defoamer 510 is added at 0.005–0.02 wt% into the slurry before jet cooking and at 0.01–0.05 wt% during fermenter charging. The lower pre-cook dose suppresses liquefaction tank foam without reducing α-amylase activity. The fermenter dose is continuously split across 6–10 additions rather than a single bolus because polyether antifoam above 0.1 wt% is associated in plant audits with reduced peak CO₂ evolution rate and ethanol titre loss, although published data for this specific configuration is limited. Non-silicone chemistry is preferred in this circuit because silicone droplets can volatilise and re-deposit as silica scale on beer column reboiler and thin-film evaporator surfaces; polyether decomposition products remain water-soluble and exit the plant in whole stillage. Terminal streams are fuel ethanol, distillers grains with solubles, and corn oil. Residual antifoam in DDGS must remain below the limits established for animal feed under the plant’s feed safety programme and the applicable FDA 21 CFR 173.340 framework.

During lyophilised probiotic starter production with Lactobacillus rhamnosus, the fermentation medium contains skim milk solids 20–40 g/L, yeast extract 5–10 g/L, and glucose 20 g/L at pH 6.2–6.5 and 37 °C. Headspace gas is nitrogen or a 90:10 N₂/CO₂ mixture at 0.05–0.15 vvm, so foam height is lower than in aerobic bacterial processes but still problematic because casein micelles and whey protein aggregates adsorb at the air–liquid interface and form stiff films during sampling and pH-adjustment cycles. Defoamer 510 is charged at 0.01–0.05 g/L; if foam rises above 15 cm on a side-port probe, incremental additions of 0.01 g/L are made no more frequently than 30 min apart. The binding constraint is not kLa depression but cell-envelope integrity: polyether molecules can intercalate into the cell envelope and modify surface hydrophobicity, which in turn reduces adhesion to intestinal epithelial cells in downstream probiotic activity assays. Overcharging above 0.1 g/L has been associated with a 0.3–0.5 log CFU/mL reduction in viable counts after freeze-drying in some development batches, though published data for this specific configuration is limited and must be confirmed on a strain-by-strain basis. Harvested cells are concentrated by continuous centrifugation to 10¹⁰–10¹¹ CFU/mL, lyophilised, and blended as direct vat set or sachet formulations. Residual antifoam must not obstruct powder wetting or reconstitution at 37 °C; therefore a rinsability test is included in the finished-powder release panel beside ISO 3219 viscosity and ASTM E2407 foam collapse data on the undiluted product.

When filamentous pellet morphology shifts to dispersed hyphae in citrate fermentation

Aspergillus niger submerged citric acid production frequently uses sucrose or cane molasses with initial sugar concentrations of 140–180 g/L under nitrogen limitation at 28–32 °C and pH falling from 5.5 to below 2.0 by the acid accumulation phase. Foam is stabilised by molasses humic colloids, fungal hydrophobins, and extracellular polysaccharides, particularly after 72 h when the broth darkens and apparent viscosity increases. Defoamer 510 is charged at 0.15–0.4 g/L and then delivered by a foam-probe actuated peristaltic pump at 0.02–0.06 g/L/h. The polyether structure remains active at pH 2.0 because the ether backbone is not hydrolytically cleaved within the 6–8 day cycle, whereas ester-containing antifoams may undergo acid hydrolysis and lose surface activity. The dominant process conflict is morphological: excessive antifoam concentration above 0.6 g/L can reduce mean pellet diameter and promote dispersed hyphal growth, raising broth apparent viscosity from approximately 50 mPa·s to values above 150 mPa·s at 10 s⁻¹. This viscosity shift reduces mixing time in a 10 m³ airlift reactor and can depress citric acid titre by 8–15 g/L relative to pellet-controlled batches. Conversely, under-dosing leads to foam carryover into the acid recovery line, contaminating rotary drum filter cloth and gypsum by-product. The terminal product is citric acid monohydrate for food, pharmaceutical, and industrial chelation uses; residual antifoam must be below the limits set by the buyer’s food additive specification and the manufacturer’s REACH (EC) 1907/2006 registration dossier.

High-density E. coli pre-induction foam surge and fed-batch oxygen transfer constraints

Recombinant Escherichia coli fermentation for inclusion-bound or soluble enzyme production uses defined glucose–mineral medium in a 500 L to 2,000 L stainless-steel bioreactor with DO-stat glucose feeding. The culture is held at pH 6.8–7.2 and 37 °C until OD₆₀₀ reaches 60–120; then temperature is shifted to 28–30 °C and IPTG is added at 0.1–1.0 mM. Foam surge occurs in the pre-induction window when cell lysis releases plasmid DNA, outer membrane vesicles, and acetate-induced stress proteins. Defoamer 510 is maintained at 0.05–0.2 g/L and added through a sterilised feed line; the feed rate is ramped alongside glucose flow from 0.05–0.15 g/L/h during the transition. The critical limit is 0.3 g/L because higher concentrations lower kLa and increase dissolved CO₂, which can transiently acidify the cytoplasm and reduce specific productivity. Non-silicone polyether is selected over silicone because downstream clarification uses 0.2 μm PVDF tangential flow microfiltration and anion-exchange chromatography; silicone droplets can blind the membrane and elute as hydrophobic contaminants in the polishing step. Defoamer 510 passes through the used membrane retentate with cell debris and is cleared during cation-exchange polishing. The terminal product is a recombinant enzyme or washed inclusion body intermediate, and the process stream is tested for residual antifoam by extraction and HPLC quantification where the host process is shared with biopharmaceutical manufacturing. Published data for this specific configuration is limited for post-induction polyether clearance efficiency, so each downstream step must be spiked and quantified before setting final release limits.

In acetone–butanol–ethanol fermentation with Clostridium acetobutylicum, gas evolution during acidogenic and solventogenic phases is intrinsic to metabolic acetate and butyrate conversion, with evolved H₂ and CO₂ creating persistent low-density foam in a corn- or wheat-based mash. Temperature is maintained at 37 °C, pH at 4.5–6.0, and total solvent titre commonly reaches 12–20 g/L with butanol at 6–13 g/L. Defoamer 510 is added at 0.02–0.1 g/L and then fed continuously at 0.01–0.04 g/L/h during the solventogenic phase, when butanol accumulation destabilises the cell membrane and releases intracellular lipids that intensify foam. The non-silicone polyether does not reduce interfacial area sufficiently to collapse all gas hold-up in an anaerobic stirred-tank reactor; instead, it shortens lamella lifetime and prevents gas-blanket formation above the liquid surface. Overfeeding above 0.2 g/L can alter phase separation behaviour in subsequent distillation because polyether partitioning into the butanol-rich organic layer can stabilise microemulsion regions between water and butanol, increasing energy demand in the decanter. Published data for this specific configuration is limited for the emulsion stabilization boundary, and a decantation jar test at 38 °C is recommended before raising the feed rate. Terminal products are n-butanol, acetone, and ethanol; the stillage is evaluated for residual polyether before animal feed or biogas co-product release under the plant’s feed safety programme and applicable national feed hygiene regulation.